85-6250-05　FAM80A Polyclonal Antibody 100ul　BT-AP03154

特徴

• 背景：RIMKLA (N-acetylaspartyl-glutamate synthetase A) is a 391 amino acid protein that belongs to the rimK family. Localizing to cytoplasm, RIMKLA contains one ATP-grasp domain and binds two manganese ions per subunit. RIMKLA catalyzes the synthesis of N-acetylaspartyl-glutamate (NAAG). RIMKLA, is almost exclusively expressed in the CNS, whereas RIMKLB, which shares 65% sequence identity with RIMKLA, is expressed in CNS and testis. It has also been suggested that RIMKLA and RIMKLB also served to ligate free glutamate to (an) acceptor (s). RIMKLA catalyzed the ATP-dependent synthesis of N-acetylaspartylglutamate (NAAG) from N-acetylaspartate and L-glutamate. RIMKLB catalyzed this reaction as well as the synthesis of β-citrylglutamate. The RIMKLA gene is conserved in chimpanzee, dog, cow and mouse, and maps to human chromosome 1p34.2.

仕様

• サイズ：100ul
• 抗原：The antiserum was produced against synthesized peptide derived from human RIMKA. AA range:112-161
• 免疫動物：Rabbit
• 交差性：Human;Mouse;Monkey
• 適用：WB, ELISA
• クラス：IgG
• クロナリティ：Polyclonal
• 濃度：1 mg/ml
• 別名：RIMKLA; FAM80A; N-acetylaspartyl-glutamate synthetase A; NAAG synthetase A; NAAGS; Ribosomal protein S6 modification-like protein A
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]